Skip to content

Clinical trials

Autoimmune Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20121
20132
20171
20182
20191
20202
20213
20223
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting5
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
GlaxoSmithKline3
AstraZeneca2
Eli Lilly and Company2
Takeda2
Beeline Medicines Corporation1
Bristol-Myers Squibb1
Erasmus Medical Center1
Human Genome Sciences Inc., a GSK Company1
Immunovant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases24
Immune System Diseases12
Connective Tissue Diseases7
Lupus Erythematosus, Systemic7
Arthritis, Rheumatoid2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemorrhage2
Hemorrhagic Disorders2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.